Harout Semerjian, Chief Executive Officer at GLYCOMIMETICS INC (GLYC), bought 25,000 shares at $1.29 ($32K) on 2022-11-11, disclosed to the SEC on 2022-11-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.